Intuitive Surgical Sales Reps Target “Hybrid” Cardiac Interventionalists
This article was originally published in The Gray Sheet
Executive Summary
Intuitive Surgical's 100-rep U.S. direct sales force will promote the da Vinci robotic surgery system to physicians who perform both coronary stenting and bypass surgery, following 510(k) clearance of an expanded indication
You may also be interested in...
Intuitive Surgical Aims da Vinci System At Hospitals In Mid-Sized Markets
Intuitive Surgical will promote its da Vinci minimally invasive robotic surgery system as a way for hospitals in medium-size markets to differentiate themselves from competing facilities and increase patient capacity
Expanded Claims, Marketing Ahead For Intuitive Da Vinci; Zeus R&D Halted
Intuitive Surgical will terminate development of the Zeus robotic surgery system, which the company acquired through the $63 mil. purchase of Computer Motion in June
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.